X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Procter & Gamble Health with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs BIOCON - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH BIOCON PROCTER & GAMBLE HEALTH/
BIOCON
 
P/E (TTM) x 60.7 17.6 344.3% View Chart
P/BV x 10.6 2.8 381.2% View Chart
Dividend Yield % 0.3 0.4 76.9%  

Financials

 PROCTER & GAMBLE HEALTH   BIOCON
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-17
BIOCON
Mar-18
PROCTER & GAMBLE HEALTH/
BIOCON
5-Yr Chart
Click to enlarge
High Rs1,3581,188 114.3%   
Low Rs933305 305.9%   
Sales per share (Unadj.) Rs665.068.7 967.7%  
Earnings per share (Unadj.) Rs56.67.6 749.1%  
Cash flow per share (Unadj.) Rs72.514.0 518.8%  
Dividends per share (Unadj.) Rs15.001.00 1,500.0%  
Dividend yield (eoy) %1.30.1 977.7%  
Book value per share (Unadj.) Rs441.786.3 511.6%  
Shares outstanding (eoy) m16.60600.00 2.8%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x1.710.9 15.9%   
Avg P/E ratio x20.298.9 20.5%  
P/CF ratio (eoy) x15.853.4 29.6%  
Price / Book Value ratio x2.68.6 30.0%  
Dividend payout %26.513.2 200.2%   
Avg Mkt Cap Rs m19,011447,900 4.2%   
No. of employees `0001.56.1 25.1%   
Total wages/salary Rs m1,6969,311 18.2%   
Avg. sales/employee Rs Th7,150.06,705.8 106.6%   
Avg. wages/employee Rs Th1,098.71,514.2 72.6%   
Avg. net profit/employee Rs Th608.2736.9 82.5%   
INCOME DATA
Net Sales Rs m11,04041,234 26.8%  
Other income Rs m2402,062 11.6%   
Total revenues Rs m11,27943,296 26.1%   
Gross profit Rs m1,3768,291 16.6%  
Depreciation Rs m2643,851 6.9%   
Interest Rs m0615 0.0%   
Profit before tax Rs m1,3525,887 23.0%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5831,569 37.1%   
Profit after tax Rs m9394,531 20.7%  
Gross profit margin %12.520.1 62.0%  
Effective tax rate %43.126.7 161.8%   
Net profit margin %8.511.0 77.4%  
BALANCE SHEET DATA
Current assets Rs m7,52341,486 18.1%   
Current liabilities Rs m2,25321,413 10.5%   
Net working cap to sales %47.748.7 98.1%  
Current ratio x3.31.9 172.4%  
Inventory Days Days5264 81.5%  
Debtors Days Days4194 43.1%  
Net fixed assets Rs m1,24050,661 2.4%   
Share capital Rs m1663,000 5.5%   
"Free" reserves Rs m7,16748,808 14.7%   
Net worth Rs m7,33351,808 14.2%   
Long term debt Rs m017,898 0.0%   
Total assets Rs m9,91299,897 9.9%  
Interest coverage xNM10.6-  
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.10.4 269.8%   
Return on assets %9.55.2 183.9%  
Return on equity %12.88.7 146.4%  
Return on capital %20.89.6 215.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,01512,058 8.4%   
Fx outflow Rs m3,0437,348 41.4%   
Net fx Rs m-2,0284,710 -43.1%   
CASH FLOW
From Operations Rs m5376,621 8.1%  
From Investments Rs m-476-6,840 7.0%  
From Financial Activity Rs m-220-2,397 9.2%  
Net Cashflow Rs m-160-2,612 6.1%  

Share Holding

Indian Promoters % 0.0 40.4 -  
Foreign collaborators % 51.8 20.6 251.5%  
Indian inst/Mut Fund % 18.2 8.4 216.7%  
FIIs % 1.0 10.7 9.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 19.9 146.2%  
Shareholders   28,591 109,995 26.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   TTK HEALTHCARE  ALEMBIC LTD  CIPLA  ELDER PHARMA  UNICHEM LAB  

Compare PROCTER & GAMBLE HEALTH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Yes Bank's Road Ahead(Podcast)

The stock markets witnessed selling pressure in the week gone by. Market participants remained cautious tracking tepid quarterly earnings amid weak cues.

Related Views on News

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jul 19, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 5-YR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS